𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗦𝗲𝗽𝘀𝗶𝘀 𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻: 𝗧𝗵𝗲 𝗩𝗦𝗡𝗢™ 𝗕𝗿𝗲𝗮𝘁𝗵 𝗔𝗻𝗮𝗹𝘆𝘇𝗲r
Sepsis is a life-threatening condition that demands rapid diagnosis and intervention. Traditional diagnostic methods can be slow and often require invasive blood draws.
The VSNO™ Breath Analyzer by Vail Scientific, LLC, developed in collaboration with Minnetronix Medical, offers a non-invasive, portable, and rapid approach to screening for early signs of sepsis. Designed to analyze exhaled nitric oxide levels, the VSNO™ can deliver results in as little as two minutes, allowing healthcare teams to make faster, more informed decisions.
Key features include:
- 𝗖𝗼𝗺𝗽𝗮𝗰𝘁 𝗗𝗲𝘀𝗶𝗴𝗻: Redesigned to be 75% smaller than the previous prototype, making it easier to mount on IV poles for bedside use.
- 𝗨𝘀𝗲𝗿-𝗙𝗿𝗶𝗲𝗻𝗱𝗹𝘆 𝗜𝗻𝘁𝗲𝗿𝗳𝗮𝗰𝗲: Patients simply exhale into the device for quick, non-invasive analysis.
- 𝗛𝗶𝗴𝗵 𝗦𝗲𝗻𝘀𝗶𝘁𝗶𝘃𝗶𝘁𝘆: Engineered to detect sepsis-related biomarkers at parts-per-billion levels, supporting earlier clinical insights.
With sepsis remaining a leading cause of hospital deaths, innovations like the VSNO™ represent an important step forward in critical care technology. That’s why Exit 156 Capital is proud to partner with companies like Vail Scientific as they help to reshape the future of critical care.
🔗 Learn more about this breakthrough innovation: https://www.designnews.com/medical/breath-based-sepsis-screening-vail-scientific-minnetronix-develop-portable-vsno-device
